|
Study of Proteus Syndrome and Related Congenital Disorders Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Study of Proteus Syndrome and Related Congenital Disorders conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Study of Proteus Syndrome and Related Congenital Disorders Clinical research trials and Study of Proteus Syndrome and Related Congenital Disorders healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Study of Proteus Syndrome and Related Congenital Disorders. Study of Proteus Syndrome and Related Congenital Disorders Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Study of Proteus Syndrome and Related Congenital Disorders clinical trial. Participants typically obtain the most effective healthcare available for their Study of Proteus Syndrome and Related Congenital Disorders condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Proteus Syndrome and Related Congenital Disorders  Study of Proteus Syndrome and Related Congenital Disorders
Study of Proteus Syndrome and Related Congenital Disorders
For Condition: Growth Disorder,Mental Retardation,Multiple Abnormalies
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will examine rare congenital disorders that involve malformations and abnormal growth. It will focus on patients with Proteus syndrome, whose physical features are characterized by overgrowth, benign tumors of fatty tissue or blood vessels, asymmetric arms or legs, and large feet with very thick soles. The study will explore the genetic and biochemical cause and course of the disease, the changes in symptoms over time, and the effects of the disease on patients. Patients with Proteus syndrome and their parents may be eligible for this study. Parents will be studied, when possible, for comparison of molecular findings. Study candidates will have a medical history and physical examination, including X-rays and possibly other imaging tests, such as computerized tomography (CT), magnetic resonance imaging (MRI) and ultrasound. Other tests and examinations may be done if needed. Those enrolled in the study will have will be interviewed or complete questionnaires, or both, about how their disease affects them. (Parents will be asked about their feelings about having a child with a rare disorder.) Patients will provide a small blood sample for research and may be asked to undergo biopsies from a normal area of skin and from a tumor.
Details: The purpose of this project is to determine the natural history and etiology of Proteus syndrome. The natural history and the phenotypic range will be determined by clinical assessment and longitudinal follow-up of a cohort of patients. Subjects will be screened for eligibility using published diagnostic criteria for Proteus syndrome. The determination of the molecular etiology of this disorder will be difficult. It is extremely rare, affected patients have a shortened lifespan, and the disorder is sporadic. Thus the typical approach of positional cloning is not useful. The etiology of this disorder will be studied using various comparative molecular biology techniques including cDNA arrays, genomic arrrays, subtractive techniques, testing of candidate genes, and other appropriate techniques. We will also test for dysregulation of growth controlling hormones and binding proteins in vivo. Note is made that although this protocol is currently structured to recruit only subjects with Proteus syndrome, it was previously used for a more general group of sporadic birth defect syndromes. The original goals for that group have been accomplished, which was the determination of the frequency of submicroscopic chromosomal rearrangements and uniparental disomy. That group of patients (and unaffected parents) is no longer being recruited but the specimens are retained. These specimens will be tested for appropriate candidate genes if, and when, that opportunity should arise.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: For Proteus Patients All affected sugjects should have the following general criteria: mosaic distribution of lesions, progressive course, and sporadic occurrence. In addition, they should have either 1 from A, 2 from B or 3 from C. A. Connective tissue nevus. B. Epidermal nevus, Disproportionate overgrowth, specific tumors before the age of 30 yrs (bilat. ovarian cystadenomas or monomorphic parotid adenoma). C. Dysregulated adipose tissue, Vascular malformations, Facial phenotype. The Proteus send-in subjects must meet the same eligibility standards as those who come to the clinical center and this will be determined by the review of the materials.
Total Enrollment: 1500
Location and Contact Information:
National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 940132; 94-HG-0132
Study Start Date: April 18, 1994
Record last reviewed: April 15, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001403
Other Mental Retardation Studies:
1. Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
2. Study of Proteus Syndrome and Related Congenital Disorders
3. Evaluation of Patients with Unresolved Chromosome Abnormalities
4. Study of Smith-Lemli-Opitz Syndrome
5. Self-Injury: Diagnosis and Treatment
Related Studies:
Other Mental Retardation Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Study of Proteus Syndrome and Related Congenital Disorders
|
|
|
|
|
|
|
|
